Impaired pulmonary nitric oxide bioavailability in pulmonary tuberculosis: Association with disease severity and delayed mycobacterial clearance with treatment
Journal of Infectious Diseases, ISSN: 0022-1899, Vol: 208, Issue: 4, Page: 616-626
2013
- 31Citations
- 66Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations31
- Citation Indexes30
- 30
- CrossRef18
- Policy Citations1
- Policy Citation1
- Captures66
- Readers66
- 66
Article Description
Background. Nitric oxide (NO), a key macrophage antimycobacterial mediator that ameliorates immunopathology, is measurable in exhaled breath in individuals with pulmonary tuberculosis. We investigated relationships between fractional exhale NO (FE) and initial pulmonary tuberculosis severity, change during treatment, and relationship with conversion of sputum culture to negative at 2 months. Methods. In Papua, we measured FE in patients with pulmonary tuberculosis at baseline and serially over 6 months and once in healthy controls. Treatment outcomes were conversion of sputum culture results at 2 months and time to conversion of sputum microscopy results. Results. Among 200 patients with pulmonary tuberculosis and 88 controls, FE was lower for patients with pulmonary tuberculosis at diagnosis (geometric mean FE, 12.7 parts per billion [ppb]; 95% confidence interval [CI], 11.6-13.8) than for controls (geometric mean FE, 16.6 ppb; 95% CI, 14.2-19.5; P =. 002), fell further after treatment initiation (nadir at 1 week), and then recovered by 6 months (P =. 03). Lower FE was associated with more-severe tuberculosis disease, with FE directly proportional to weight (P <. 001) and forced vital-capacity (P =. 001) and inversely proportional to radiological score (P =. 03). People whose FE increased or remained unchanged by 2 months were 2.7-fold more likely to achieve conversion of sputum culture than those whose FE decreased (odds ratio, 2.72; 95% CI, 1.05-7.12; P =. 04). Conclusions. Among patients with pulmonary tuberculosis, impaired pulmonary NO bioavailability is associated with more-severe disease and delayed mycobacterial clearance. Measures to increase pulmonary NO warrant investigation as adjunctive tuberculosis treatments. © The Author 2013.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84880934841&origin=inward; http://dx.doi.org/10.1093/infdis/jit248; http://www.ncbi.nlm.nih.gov/pubmed/23737604; https://academic.oup.com/jid/article-lookup/doi/10.1093/infdis/jit248; https://dx.doi.org/10.1093/infdis/jit248; https://academic.oup.com/jid/article-abstract/208/4/616/920444?redirectedFrom=fulltext
Oxford University Press (OUP)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know